No Detail Found!

Antiviral therapy for COVID-2019

Author(s)
Hanik Badriyah Hidayati Department of Neurology, Faculty of Medicine, Universitas Airlangga/ Dr. Soetomo General Hospital,Surabaya, Indonesia
Evi Octavia Hospital Pharmacy Installation of Dr. Soetomo General Hospital,Surabaya, East Java,Indonesia
Cempaka Thursina Srisetyaningrum Department of Neurology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
Abstract
The whole world is experiencing a global pandemic caused by Coronavirus disease 2019. As the pandemic progresses, there has been much research on antiviral drugs, such as hydroxychloroquin, chloroquine, remdesivir, lopinavirritonavir, favipiravir, oseltamivir, and umifenovir. Specific antiviral drugs proven to be effective against SARS-CoV-2 have not been found and approved for the medication of COVID-19. Currently, case detection, infection control, monitoring, prevention, and supportive care are the means focused on the treatment of COVID-19. A large scale research is currently underway to analyze safety and efficacy of antiviral drugs, while trials of the SAR-CoV-2 vaccine are rapidly expanding. This mini review briefly introduces the current antiviral therapy for COVID-19. 
Publication Details
Page(s) 387-390
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 25, Issue: 3, Year: 2021

Request the full text from PASTIC

Keywords
drugs, COVID-19, Antiviral therapy
0

Citations

0

Downloads

55

Views